Rallis India Ltd Q3 FY26 Earnings Analysis

Published 21 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹4.2K Cr

Price

213

Market Cap

₹4.2K Cr

P/E Ratio

18.4

How does Rallis India Ltd rank in Fertilizers & Agrochemicals?

Compare Rallis India Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

Rallis India Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹456 Cr, net profit ₹-15 Cr.

Full financials →

Earnings Summary

Aim to grow company revenue in double digits over the next 5 years. Rallis India aspires to double-digit revenue growth over the next 5 years.

📊 Revenue & Sales Performance

  • Aim to grow company revenue in double digits over the next 5 years.
  • Seed business expected to grow significantly with new product launches in cotton, maize, rice, bajra.
  • Soil and plant health business targeted to grow 4x from INR 225 crores to INR 700-800 crores.
  • CSM business growth to contribute, but large molecule opportunities currently limited.
  • Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness.
  • Export business grew ~73%, seeds 46%, soil & plant health 16% in recent quarters.
  • Focus on digital initiatives and expanding customer base to drive demand.
  • Operating leverage expected to improve margins with better utilization and fixed cost control.
  • Inventory planned carefully to meet seasonal demand, with healthy momentum.

📈 Profitability & Margins

  • Rallis India aspires to double-digit revenue growth over the next 5 years.
  • Targeting a 500 basis points (5%) expansion in blended EBITDA margins within 5 years.
  • Margin improvements primarily expected through operating leverage rather than gross margin gains.
  • Seed business margins aimed to improve significantly, potentially reaching mid-20s percentage margins over time.
  • Seed segment expected to grow robustly, targeting near ₹1,000 crore revenue.
  • Soil and Plant Health segment aims 4x growth from ₹225 crore to ₹700-800 crore.
  • CSM business seen as high-margin but currently small; future contracts may lift margins modestly.
  • Near-term challenges include market-specific crop performance, competitive intensity, and pricing pressures especially from Chinese suppliers.
  • Management cautiously optimistic but avoids specific short-term earnings/pat guidance due to uncertainties like weather, crop prices, and geopolitical risks.

🏗️ Capital Expenditure Plans

  • Rallis India Limited is cautious with capital expenditure (capex), avoiding significant investments unless there is firm market demand or contracts.
  • Sufficient existing infrastructure: current plants and equipment support ongoing growth without the need for major new capex.
  • Only sustainable, ongoing capex is planned to maintain operations.
  • The company remains open to inorganic growth opportunities and may utilize cash reserves for strategic investments in its three key verticals.
  • No large-scale or high-value CSM (Custom Synthesis & Manufacturing) contract opportunities (~INR 500 crores) are currently available.
  • Investments will focus on maintaining operational efficiency, supporting new product launches, and leveraging existing assets rather than aggressively expanding capacity ahead of demand.

💰 Fundraising & Capital Structure

  • Rallis India Limited does not plan to undertake any significant capex unless there is firm market demand.
  • The company currently has enough plants and equipment to support growth, implying limited immediate need for large-scale funding.
  • Any future capex will be sustainable and planned, not aggressive or speculative.
  • The company maintains healthy cash and liquid balances (₹455 crore as of December 31, 2025).
  • Cash on the balance sheet is primarily used for working capital and potential inorganic growth opportunities in existing verticals.
  • There is no explicit mention of new fundraising through debt or equity in the near future.
  • The focus is on capital efficiency and disciplined working and fixed capital management.

📋 Order Book & Pipeline

The transcript does not explicitly mention details about the current or expected order book or pending orders for Rallis India Limited. However, relevant insights related to order management and inventory include: - The company has planned sufficient inventory for all crops for the upcoming year, aiming to avoid past supply disruptions. - Inventory levels remain slightly elevated compared to the previous year, but collections remain smooth. - Rallis is focused on rationalizing the portfolio, sharpening priority markets, and expanding the customer base. - The placement of products is carefully tracked to avoid overstocking; liquidation of inventory is ongoing. - The business remains sensitive to seasonal demand cycles, with monitored receivables indicating stable marketplace conditions. - Export business and domestic segments show strong growth, suggesting healthy order inflows aligned with demand. No specific quantitative order book figures or pending orders are disclosed in the transcript.

Key Metrics

Frequently Asked Questions

What were Rallis India Ltd Q3 FY26 results?

Aim to grow company revenue in double digits over the next 5 years. Rallis India aspires to double-digit revenue growth over the next 5 years.

What is Rallis India Ltd share price analysis?

Rallis India Ltd currently shows a neutral. The stock trades at a P/E of 18.4 with a market cap of ₹4,208 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rallis India Ltd planning capital expenditure?

Rallis India Limited is cautious with capital expenditure (capex), avoiding significant investments unless there is firm market demand or contracts.

Keep Rallis India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Fertilizers & Agrochemicals this season

  • Sharda Cropchem Ltd (Q3 FY26)

    Capex planned in the range of INR 450-500 crores to support growth and registration activities. Sharda Cropchem Ltd Q3 FY26 results — Market Cap ₹7,424 Cr…

  • Krishana Phoschem Ltd (Q3 FY26)

    It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Krishana Phoschem Ltd Q3 FY26 results…

  • Paradeep Phosphates Ltd (Q3 FY26)

    Sustainable EBITDA per ton likely to improve by 30-35% once all sites achieve 100% backward integration (Page 13). Paradeep Phosphates Ltd Q3 FY26 results…

  • Dhanuka Agritech Ltd (Q3 FY26)

    60-70 crores. Dhanuka Agritech Ltd Q3 FY26 results — Market Cap ₹4,482 Cr, P/E 16.7.